Now showing items 1-1 of 1

    • Modified vaccinia virus ankara preferentially targets antigen presenting cells in vitro, ex vivo and in vivo 

      Altenburg, Arwen F.; van de Sandt, Carolien E.; Li, Bobby W. S.; MacLoughlin, Ronan J.; Fouchier, Ron A. M.; van Amerongen, Geert; Volz, Asisa; Hendriks, Rudi W.; de Swart, Rik L.; Sutter, Gerd; Rimmelzwaan, Guus F.; de Vries, Rory D. (Springer Nature, 2017-08-17)
      Modified Vaccinia virus Ankara (MVA) is a promising vaccine vector with an excellent safety profile. However, despite extensive pre-clinical and clinical testing, surprisingly little is known about the cellular tropism of ...